The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Comparative efficacy and safety of donafenib versus bevacizumab in combination with immune checkpoint inhibitors and interventional therapy for advanced hepatocellular carcinoma: A retrospective cohort study.
 
Zhaolong Pan
No Relationships to Disclose
 
Junbo Cao
No Relationships to Disclose
 
Dongming Liu
No Relationships to Disclose
 
Lu Yang
No Relationships to Disclose
 
Haijing Zheng
No Relationships to Disclose
 
Dongyang Li
No Relationships to Disclose
 
Chen Liu
No Relationships to Disclose
 
Linlin Fu
No Relationships to Disclose
 
Guangtao Li
No Relationships to Disclose
 
Xiaomeng Liu
No Relationships to Disclose
 
Xu Bao
No Relationships to Disclose
 
Ping Chen
No Relationships to Disclose
 
Feng Fang
No Relationships to Disclose
 
Huikai Li
No Relationships to Disclose
 
Yunlong Cui
No Relationships to Disclose
 
Tianqiang Song
No Relationships to Disclose
 
Wei Zhang
No Relationships to Disclose